As many as 65 children in Uzbekistan died after being given the Indian cough and cold syrup "Doc-1 Max", a representative of the Uzbek Supreme Court said on August 11. Officials in the country have previously only referred to around 20 victims.
A criminal case centred on the deaths caused by the contaminated medicine began on August 11 in Uzbekistan. The court heard that 21 people, all Uzbek citizens apart from one citizen of India, who is the director of Quramax Medikal, were being held in the case.
Charges pressed include tax evasion, the production, manufacture, acquisition, storage, transportation for sale or sale of substandard or falsified medicines or medical products, abuse of office, negligence, forgery and bribery.
In December 2022, the cough syrup Doc-1 Max, produced by Indian company Marion Biotech, was associated with the deaths of at least 20 children in Uzbekistan.
The Indian regulator later cancelled the manufacturing licence of Marion Biotech, which exported the medicines to Uzbekistan, and arrested some of its employees.
Related Articles
Asian LNG spot market prices dip amid weak demand and high inventories
Prices on the Asian LNG spot market slid for the first time in five weeks, Reuters reported on June 6. Weak demand in the region saw the average LNG price for July delivery fall to $12.30 per ... more
ASIA BLOG: How US tariffs are driving Asia closer to itself – and China
When the United States slapped a universal 10% tariff on all imports earlier this year, followed by the threat of even steeper penalties for countries running trade surpluses with Washington, many ... more
Indian refiners pivot to Middle East following fresh US sanctions
New US sanctions pushed Indian state refiners to request Abu Dhabi National Oil Co. (ADNOC) to price its crude on a delivered basis on Tuesday, 21 January after freight rates rose sharply this week, ... more
Most Read
-
Putin to skip Rio BRICS summit over ICC warrant as Xi signals no-show
15 days ago
-
Turkey yet to prove rare earth deposit has suggested “giant” potential despite reported processing talks with China
10 months ago
-
Uproar in Mongolia as development bank reveals scale of risky loans and NPLs
3 years ago